Stéphane Bancel is the CEO of Moderna, a biotech firm known for its groundbreaking COVID-19 vaccine based on messenger RNA technology. Since joining the company in 2011, Bancel has led Moderna from a startup to a global commercial enterprise, developing numerous mRNA therapeutic and vaccine programs, and significantly impacting the biotech industry.
Who is the CEO of Moderna?
Stéphane Bancel, born in Marseille, France, is a French business executive. Before joining Moderna as CEO in 2011, Bancel served as the CEO of French diagnostics company bioMérieux SA and held various roles at Eli Lilly and Company.
As the CEO of Moderna, Bancel has been instrumental in the company's growth and success, particularly in the development and approval of its COVID-19 vaccine using messenger RNA technology. Under his leadership, Moderna has become a pioneer in mRNA technology and a key player in the biotech industry.
Work History
- Moderna - Founding CEO: 2011 - Present
- QIAGEN - Board Director: 2013 - Present
- Knome Inc - Board Director: 2008 - 2013
- bioMérieux - CEO: 2007 - 2011
- Eli Lilly - Country Manager, Belgium: 2004 - 2006
- Eli Lilly - Executive Director, Global Manufacturing Strategy and Global Supply Chain: 2003 - 2004
- Eli Lilly - Director, Global Manufacturing Strategy: 2002 - 2003
- Eli Lilly - Manager, Supply Chain: 2000 - 2002
- bioMérieux Asia-Pacific - Sales & Marketing Director: 1995 - 1998
Education History
Stéphane Bancel has an impressive educational background, beginning with a Master of Engineering (M.Eng.) in Chemical and Biomolecular Engineering from CentraleSupélec, which he obtained between 1992 and 1995.
During his time at CentraleSupélec, Bancel also pursued a M.Sc. in Chemical Engineering at the University of Minnesota, completing the degree in 1995. He later went on to earn his MBA from Harvard Business School between 1999 and 2000, further solidifying his expertise in both the technical and business aspects of his career.
When did Stéphane Bancel join Moderna?
Stéphane Bancel founded Moderna in 2010 and has been serving as its CEO since 2011. As the founding CEO, Bancel has played a crucial role in the company's growth and success, particularly in the development of its COVID-19 vaccine using messenger RNA technology. As of now, Bancel has been with Moderna for over a decade, leading the company from its inception to its current status as a pioneer in the biotech industry.